期刊
CLINICAL MICROBIOLOGY AND INFECTION
卷 20, 期 10, 页码 973-980出版社
ELSEVIER SCI LTD
DOI: 10.1111/1469-0691.12798
关键词
Antibiotic resistance; attributable morbidity and mortality; economics
资金
- Science and Technology Directorate, Department of Homeland Security [HSHQDC-12-C-00058]
- Global Antibiotic Resistance Partnership - Bill & Melinda Gates Foundation
The declining effectiveness of antibiotics imposes potentially large health and economic burdens on societies. Quantifying the economic outcomes of antibiotic resistance effectively can help policy-makers and healthcare professionals to set priorities, but determining the actual effect of antibiotic resistance on clinical outcomes is a necessary first step. In this article, we review and discuss the contributions and limitations of studies that estimate the disease burden attributable to antibiotic resistance and studies that estimate the economic burden of resistance. We also consider other factors that are important in a comprehensive approach to evaluating the economic burden of antibiotic resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据